Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Abbas Hussain

At a glance: Abbas Hussain is Director at Moderna (MRNA). Their latest SEC Form 4, filed May 4, 2026, reported a sale of $265K. On file: 0 purchase lines ($0) and 2 sale lines ($279K).

Disclosed holdings: about $2.4M of MRNA stock: 12,066 shares reported on their latest Form 4 (filed May 4, 2026), valued at the Nov 19, 2026 close of $200.20. This counts only MRNA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Moderna, Inc. (MRNA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $279K

Abbas Hussain's InsiderPrint

2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Abbas Hussain: 2 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 1 sale
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
May 4SEC MRNAModerna, Inc. Sell Plan 5,68212,066 held (−32%) $46.63 $265K +329.3%
Dec 11SEC MRNAModerna, Inc. Sell Plan 5041,515 held (−25%) $27.60 $14K +625.4%
  • Sell

    Director Abbas Hussain sold $265K of MRNA at $46.63 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Abbas Hussain sold $14K of MRNA at $27.60 — pre-scheduled 10b5-1 plan sale.

Follow Abbas Hussain

Get one email when Abbas Hussain files a new purchase or sale. Free.

At most one email a day about Abbas Hussain, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.